ecNumber*3.1.13.2#turnoverNumber*-999#turnoverNumberMaximum*#substrate*more#commentary*study of the order of cleavage, most RNA fragments are cleaved by a combination of primary, secondary primary, and 5-nt cuts within 1 min#organism*Human immunodeficiency virus 1#ligandStructureId*#literature*653638#!ecNumber*3.1.13.2#turnoverNumber*-999#turnoverNumberMaximum*#substrate*more#commentary*kcat value of Avian myeloblastosis virus reverse transcriptase (RNase H reaction) is above 0.025 s-1. The kcat values for different Moloney murine leukaemia virus/Avian myeloblastosis virus chimeric reverse transcriptases with poly(rA)*p(dT)45 as a substrate: 6.3 1/s for MRT-AF, 3.8 1/s for MRT-AP, 4.6 1/s for MRT-AT, and 2.4 1/s for MRT-AR#organism*Avian myeloblastosis virus#ligandStructureId*#literature*692923#!ecNumber*3.1.13.2#turnoverNumber*-999#turnoverNumberMaximum*#substrate*more#commentary*kcat value of Moloney murine leukemia virus reverse transcriptase (RNase H reaction) above 3 ms-1. The kcat values for different Moloney murine leukemia virus/avian myeloblastosis virus chimeric reverse transcriptases with poly(rA)*p(dT)45 as a substrate: 6.3 1/s for MRT-AF, 3.8 1/s for MRT-AP, 4.6 1/s for MRT-AT, and 2.4 1/s for MRT-AR#organism*Moloney murine leukemia virus#ligandStructureId*#literature*692923#!ecNumber*3.1.13.2#turnoverNumber*0.0018#turnoverNumberMaximum*#substrate*DNA-17-nucleotide-RNA hybrid#commentary*pH 7.8, 37&deg;C, recombinant wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*#literature*664079#!ecNumber*3.1.13.2#turnoverNumber*0.0024#turnoverNumberMaximum*#substrate*poly(rA)n-poly(dT)n#commentary*mutant p66/p51C280W#organism*Human immunodeficiency virus 1#ligandStructureId*#literature*652907#!ecNumber*3.1.13.2#turnoverNumber*0.0024#turnoverNumberMaximum*#substrate*poly(rA)n-poly(dT)ne#commentary*mutant p66C280P/p51#organism*Human immunodeficiency virus 1#ligandStructureId*#literature*652907#!ecNumber*3.1.13.2#turnoverNumber*0.0025#turnoverNumberMaximum*#substrate*poly(rA)n-poly(dT)n#commentary*mutant p66/p51C280P#organism*Human immunodeficiency virus 1#ligandStructureId*#literature*652907#!ecNumber*3.1.13.2#turnoverNumber*0.0029#turnoverNumberMaximum*#substrate*poly(rA)n-poly(dT)n#commentary*mutant p66C280P/p51C280P; mutant p66C280W/p51#organism*Human immunodeficiency virus 1#ligandStructureId*#literature*652907#!ecNumber*3.1.13.2#turnoverNumber*0.0031#turnoverNumberMaximum*#substrate*poly(rA)n-poly(dT)n#commentary*wild type enzyme p66/p51#organism*Human immunodeficiency virus 1#ligandStructureId*#literature*652907#!ecNumber*3.1.13.2#turnoverNumber*0.0032#turnoverNumberMaximum*#substrate*DNA-18-nucleotide-RNA hybrid#commentary*pH 7.8, 37&deg;C, recombinant wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*#literature*664079#!ecNumber*3.1.13.2#turnoverNumber*0.0034#turnoverNumberMaximum*#substrate*poly(rA)n-poly(dT)n#commentary*mutant p66C280W/p51C280W#organism*Human immunodeficiency virus 1#ligandStructureId*#literature*652907#!ecNumber*3.1.13.2#turnoverNumber*0.0135#turnoverNumberMaximum*#substrate*DNA-15-nucleotide-RNA hybrid#commentary*pH 7.8, 37&deg;C, recombinant wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*#literature*664079#!ecNumber*3.1.13.2#turnoverNumber*0.017#turnoverNumberMaximum*#substrate*DNA-16-nucleotide-RNA hybrid#commentary*pH 7.8, 37&deg;C, recombinant wild-type enzyme#organism*Human immunodeficiency virus 1#ligandStructureId*#literature*664079#!ecNumber*3.1.13.2#turnoverNumber*0.025#turnoverNumberMaximum*#substrate*DNA-RNA hybrid#commentary*mutant enzyme H264A, at pH 7.5 and 30&deg;C#organism*Homo sapiens#ligandStructureId*#literature*729704#!ecNumber*3.1.13.2#turnoverNumber*3.5#turnoverNumberMaximum*#substrate*DNA-RNA hybrid#commentary*wild type enzyme, at pH 7.5 and 30&deg;C#organism*Homo sapiens#ligandStructureId*#literature*729704#